glp-1 agonist mechanism A Closer Look at the Dermatological Profile of Agonists GLP-1 Receptor Agonists and Myocardial

A similar story emerges when reviewing diagnosis profiles for new patients of each product type

Without understanding the pharmacology, the physical similarity reinforces the misconception

Li, Y., Liu, W., Li, L

2021;12:721198 Ethics declarations Competing interests The authors declare no competing interests

by Jennifer Lines, PharmD Candidate, PCCA Clinical Services Intern, and Catherine Henderson, PharmD, PCCA Clinical Compounding Pharmacist Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revolutionized metabolic health and weight management, leading to a host of new weight loss wonder drugs

Long-acting GLP-1 receptor agonists offer less frequent dosing and include: Dulaglutide (Trulicity) : Once-weekly injection, available in single-dose pens ranging from 0.75 mg to 4.5 mg Semaglutide (Ozempic, Wegovy) : Once-weekly injection